Showing results (21-30 of 443) with videos related to
Sort By:
Pageof 45
Frontiers in Immunology|July 23, 2020
Immunogenicity of Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A: Causes, Consequences, and MitigationRonit Mazor, Ira PastanAdvanced Drug Delivery Reviews|August 15, 2009
Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeuticsSatoshi Nagata, Ira PastanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Identification of novel human CTL epitopes and their agonist epitopes of mesothelinJunko Yokokawa, Claudia Palena, Philip Arlen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
High shed antigen levels within tumors: an additional barrier to immunoconjugate therapyYujian Zhang, Ira PastanBiomolecules|July 8, 2020
Mechanisms of Resistance to Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A in Cancer TherapyMichael Dieffenbach, Ira PastanHepatology (Baltimore, Md.)|September 15, 2019
Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum RetentionBryan D Fleming, Daniel J Urban, Matthew D Hall, et al.The FEBS Journal|May 19, 2011
A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancerJohn E Weldon, Ira PastanBest Practice & Research. Clinical Haematology|April 3, 2003
Immunobiological treatments of hairy-cell leukaemiaRobert J Kreitman, Ira PastanBest Practice & Research. Clinical Haematology|November 29, 2015
Immunoconjugates in the management of hairy cell leukemiaRobert J Kreitman, Ira PastanCurrent Drug Targets|November 1, 2006
Immunotoxins in the treatment of hematologic malignanciesRobert J Kreitman, Ira PastanPageof 45